Skip to main content

Leadership

Ali RezaiAli Rezai, MD

Executive Chair, Vice President of Neurosciences

Associate Dean, John D. Rockefeller IV tenured professor in neuroscience, West Virginia School of Medicine


Dr. Rezai earned his medical degree with honors from the University of Southern California and underwent neurosurgical training at New York University. He completed his subspecialty training in functional neurosurgery at the University of Toronto and the Karolinska Institute in Stockholm, Sweden. He then joined the neurosurgical faculty at New York University Medical Center, becoming the director of the Center for Functional and Restorative Neurosurgery until January 2000, when he joined the faculty at the Cleveland Clinic Foundation. Dr. Rezai was the director of the Center for Neurological Restoration, as well as the Jane and Lee Seidman Chair in Functional Neurosurgery at the Cleveland Clinic until August 2009, when he joined the faculty at The Ohio State University in Columbus, Ohio, where he served as associated dean of Neuroscience and the director and CEO of the OSU Neurological Institute.

A board-certified neurosurgeon, Dr. Rezai’s clinical areas of expertise are the neurosurgical management of patients with Parkinson’s disease, dystonia, chronic pain, brain and spinal cord injuries, spasticity, as well as depression and obsessive-compulsive disorder. Dr. Rezai was named one of the best doctors in America in Castle and Connolly’s Guide to America’s Top Doctors from 2001-2017.

Dr. Rezai has published more than 175 peer-reviewed articles and 40 book chapters. He serves on the editorial board of five scientific journals and has edited a book on surgery for psychiatric disorders and the two-volume textbook, Neuromodulation. In addition, Dr. Rezai has been the principal investigator (PI) and co-investigator on eight NIH grants as well as being the PI of the state of Ohio’s Neurotechnology Innovations Translator Center. Dr. Rezai has trained over 40 fellows, delivered more than 500 lectures, and chaired numerous symposia and meetings. Dr. Rezai has also presented his work to the President of the United States as well as to members of the U.S. Senate and House of Representatives on Capitol Hill. He is the past president of the Congress of Neurological Surgeons, the largest neurosurgical society in the world, as well as the past president of the North American Neuromodulation Society, and the American Society of Stereotactic and Functional Neurosurgery.

Dr. Rezai’s research focuses on the neural circuitry, neurological sensors and monitors, and the development of surgical tools and new therapeutic strategies for neurological disorders. He has been involved in developing brain pacemaker innovations for treating Parkinson’s, depression, obsessive compulsive disorders, Alzheimer’s, traumatic brain injury, and obesity. He is also developing sensors and monitors for autism, ADHD, and Alzheimer’s, as well as the use of micro implants to treat migraine headaches, asthma, chronic pain, and anxiety disorders. 

He is the recipient of the Bottrell Neurosurgical Award, the Congress of Neurological Surgeons Clinical Fellowship Award, and the American Association of Neurological Surgeons William Sweet Investigator Award. He has also received several innovation awards. He also holds 50 U.S. patents for medical devices and technologies.

Dr. Rezai’s work has been in publications such as The Wall Street Journal, The New York Times, U.S. News & World Report, USA Today, MIT’s Technology Review magazine, Newsweek, Time, The Washington Post, The Boston Globe, Reader’s Digest, The Los Angeles Times, and The Chicago Tribune. He has appeared on numerous local and national radio and television broadcasts including CBS’s 60 Minutes, The Charlie Rose Show, Prime Time, The Diane Rehm Show, CNN, NPR, PBS, the BBC, MSNBC, ABC, NBC, CBS, and The Discovery Channel.


John V. Campo, MD

John V. Campo, M.D.

Assistant Dean of Behavioral Health and Wellness, Chief Behavioral Wellness Officer

Board certified in pediatrics, psychiatry, and child and adolescent psychiatry, Dr. Campo has been consistently recognized among America’s Top Doctors and Best Doctors in America. His scholarly work focuses on mental health services, including the delivery of mental health services in general medical settings, the study and prevention of suicide, and the relationship between physical and emotional health.



Rhonda Campo

Rhonda Campo, M.B.A

Associate Vice President of Strategic Development, Commercialization, and Innovation

Dr. Campo, whose background is in the private sector biotech business and in university innovation, will focus on the vast economic development potential of the intellectual output of Rockefeller Institute faculty. Her focus will be on creating new economic opportunities in West Virginia by advancing the RNI mission.



Scott Galster, PhD

Scott Galster, Ph.D. 

Director of Human Performance

Dr. Galster is a psychologist focused on all aspects of human performance research, including physical, cognitive, behavioral, biomarker, physiological, environmental, and social measures used to assess an individual’s or team’s functional state.



Marc Haut, PhD

Marc Haut, Ph.D. 

Chair, Department of Behavioral Medicine and Psychiatry

Marc W. Haut, PhD, ABPP, is a board-certified, clinical neuropsychologist who serves as professor and chair of WVU’s Department of Behavioral Medicine and Psychiatry. He joined the WVU faculty in 1989 as an assistant professor and has been an active clinician, educator and researcher. In previous roles, he directed neuropsychology training and services and headed the psychology section. He has focused on expanding clinical psychiatric and behavioral health services to underserved areas of the state through Extension for Community Healthcare Outcomes (ECHO) programs and telepsychiatry. In addition, he is dedicated to expanding clinical services to address the current opioid epidemic. WVU is utilizing grant funding and collaborations throughout the state to expand Medication Assisted Treatment (MAT) through the use of ECHO and a hub and spoke model. Additionally, Haut has been building the research infrastructure of the department to support development of novel treatment programs to improve outcome for addiction services.

Robert Marsh, MD

Robert Marsh, M.D., Ph.D.   

Interim-Chair, Department of Neurosurgery






Randy Nelson, PhD

Randy Nelson, Ph.D.

Director of Basic Science Research

Dr. Nelson is a world-renowned neuroscientist with numerous awards and distinctions for his research and teaching. Randy’s research is advancing our understanding of the role of the circadian rhythms and sleep in health and disease.  



Karyn Wallace, MBA CNMT PET

Karyn Wallace, M.B.A., C.N.M.T., P.E.T.

Associate Vice President of Neuroscience and Radiology






David Watson, MD

David Watson, M.D.

Chair, Department of Neurology

Dr. Watson's clinical work focuses on patients with headache disorders, including migraine and cluster, as well as access to clinical care in underserved populations. He is active in clinical research focused on new treatment options for headache patients. 



Amy Bush

Amy Bush, R.N., B.S.N., M.B.A., C.N.O.R.

System Vice President, Clinical Operations